Financhill
Back

Royal Gold, Inc. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Buy
76

RGLD
Royal Gold, Inc.

Last Price:
$227.59
Seasonality Move:
14.19%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Buy
76
Royal Gold, Inc. (RGLD) is a Buy

Is Royal Gold, Inc. a Buy, Sell or Hold?

  • The current Royal Gold, Inc. [RGLD] share price is $227.64. The Score for RGLD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • RGLD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGLD Stock Price Chart

What is Royal Gold, Inc.'s stock price today?

  • The Royal Gold, Inc. share price today is $227.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLD is experiencing slight buying pressure.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.

RGLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 42.3 Buy
Relative Strength Index (14 RSI): 75.32 Buy
Chaikin Money Flow: 530171 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (189.09 - 215.95) Buy
Bollinger Bands (100): (172.51 - 203.29) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.79 Sell
Chaikin Money Flow: 9780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.35) Sell
Bollinger Bands (100): (12.23 - 15.15) Sell

RGLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 219.29 Buy
20-day SMA: 206.77 Buy
50-day SMA: 193.85 Buy
200-day SMA: 178.99 Buy
8-day EMA: 119.11 Buy
20-day EMA: 58.28 Buy
50-day EMA: 25.4 Buy
200-day EMA: 6.64 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 11.62 Sell
50-day SMA: 12.8 Sell
200-day SMA: 11.89 Sell
8-day EMA: 11.86 Sell
20-day EMA: 11.96 Sell
50-day EMA: 12.6 Sell
200-day EMA: 12.22 Sell

Royal Gold, Inc. Earnings Growth & RGLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.93 per share, and an increase next year of $3.38 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Royal Gold, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):